Austin, Texas, United States, July 31st, 2026, NewsDirect
- The company is expanding its presence in the global surgical robotics market through its proprietary SSi Mantra robotic surgery platform.
- The company’s strategy combines world-class robotic systems, including telesurgery capabilities, with affordability, physician training, and international market expansion.
- More than 200 SSi Mantra systems have been installed worldwide, supporting over 12,000 robotic procedures across more than 170 surgical indications.
- SS Innovations continues pursuing U.S. FDA clearance and European regulatory approvals while building its installed base internationally.
- Growing demand for minimally invasive surgery and broader access to robotic procedures continues to create opportunities for emerging high-tech medical technology companies.
The market for robotic-assisted surgery continues to evolve as healthcare systems seek technologies that can improve surgical precision while expanding patient access. Within that landscape, SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has positioned itself around a strategy centered on unmatched technology, physician training, international expansion, and affordability. Serving as the foundation of its commercial efforts is the company’s proprietary SSi Mantra surgical robotic system.
Unlike many developers focused primarily on premium hospital systems, SS Innovations has concentrated on reducing the economic barriers that have limited adoption of robotic surgery in many regions. The company believes lowering acquisition and operating costs can allow more hospitals to introduce robotic-assisted procedures without sacrificing advanced…
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company utilized by both public and private companies to optimize investor awareness and recognition. For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII
Contact
IBN
www.InvestorBrandNetwork.com
[email protected]